CN1083714A - A kind of cancer therapy drug of Chinese medicinal components - Google Patents
A kind of cancer therapy drug of Chinese medicinal components Download PDFInfo
- Publication number
- CN1083714A CN1083714A CN 93106194 CN93106194A CN1083714A CN 1083714 A CN1083714 A CN 1083714A CN 93106194 CN93106194 CN 93106194 CN 93106194 A CN93106194 A CN 93106194A CN 1083714 A CN1083714 A CN 1083714A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- chinese medicine
- semen
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to the field of preparing medicines, be particularly related to cancer therapy drug, 29 flavor Chinese medicine powders such as dress Rhizoma Arisaematis in it is assisted by medicinal little arogel, confused, the Rhizoma Polygoni Cuspidati of blooming are formed, the effect of have heat-clearing and toxic substances removing, removing blood stasis to reduce swelling, activating collaterals and eliminating stagnation, curing the disease, for pulmonary carcinoma, uterus carcinoma, ovarian cancer, the brain cancer, esophageal carcinoma, laryngeal carcinoma etc. better curative effect is arranged all, and be Chinese medicine west system, and a kind of anticancer drugs that have Chinese medicine and Western medicine advantage simultaneously.
Description
The present invention relates to the field of preparing medicines.
Up to the present, multiple cancer therapy drug is arranged in the world, but all have the curative effect problem or take after pay problems in role, and less the guidance from theory of Chinese medical science prepares medicines, the patent medicine of Chinese medicine west system still less, and Chinese medicine anticancer, that control cancer is confined to decoction, powder state in the past, no matter be from the grasp of dosage or taking the aspect all has difficulties, existing in addition cancer therapy drug mostly is the killing or suppress growth of cancerous cell, wait to pay acts on but simultaneously normal cell has also been produced to kill, and universal is less.More do not utilize theory of Chinese medical science people's body to be carried out comprehensively regulating from dialectical view.There is significant limitation.
The objective of the invention is to: a kind of heat-clearing and toxic substances removing is provided, removing blood stasis to reduce swelling, activating collaterals and eliminating stagnation, spleen invigorating is regulated the flow of vital energy, and is the anticancer drugs of component by Chinese medicine, and through Chinese medicine is made powdery, Chinese medicine west pharmacy product in quantitatively incapsulating make this medicine not only to various cancers therapeutical effect preferably be arranged, and the comprehensively regulating of pair person are arranged, make because the poison that chemotherapy produces is paid effect, the huge pain of health of patients with advanced cancer etc. has mitigation.
The component of cancer therapy drug of the present invention is: (% is a total weight percent)
Rhizoma Arisaematis 2.4%~3% Radix Trichosanthis 2.4%~3%
The Rhizoma Pinelliae 2.4%~3% Radix Salviae Miltiorrhizae 2.4%~3%
Radix Sophorae Tonkinensis 2.4%~3% stir-baked SQUAMA MANITIS 2.4%~3%
Carapax Trionycis 2.4%~3% Radix Scrophulariae 2.4%~3%
Rhizoma Paridis 2.4%~3% Rhizoma Dioscoreae Septemlobae 2.4%~3%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.4%~3% Radix Asparagi 3.2%~4%
Radix Ophiopogonis 3.2%~4% Radix Stemonae 3.2%~4%
Radix Platycodonis 3.2%~4% Herba Houttuyniae 3.2%~4%
The Radix Astragali 3.2%~4% Rhizoma Polygoni Cuspidati 4.8%~6%
Herba Scutellariae Barbatae 4.8%~6% Spica Prunellae 8%~10%
Herba Hedyotidis Diffusae 8%~10% Sargassum 8%~10%
Rhizoma Smilacis Glabrae 2.4%~3% Radix Et Rhizoma Rhei 0.9%~1.1%
Semen Arecae 1.6%~2% Semen Pharbitidis 1.8%~2%
Nidus Vespae 1.8%~2% Endothelium Corneum Gigeriae Galli 1.8%~2.2%
System Semen Strychni 0.22%~0.3%
Semen Arecae in the above component and Semen Pharbitidis can replace with the equivalent Polyporus.
When preparation medicine of the present invention, can follow these steps to carry out:
1, with Endothelium Corneum Gigeriae Galli, stir-baked SQUAMA MANITIS, Semen Strychni (processed), Rhizoma Paridis and Rhizoma Arisaematis are ground into fine powder, cross 100 mesh sieve standbies.
2, all the other medicament mixed, clear water is cleaned, and washes in a pan and removes silt, contains in the stainless-steel pan, adds water three sesquialters, puts on the stove fire, and slow fire boiling one hour leaches medicine juice, adds the water half as much again again, and slow fire boiling one hour leaches medicine juice, removes slag.Mix frying in shallow oil juice for twice again, filter in the stainless-steel pan, put that slow fire boiling becomes paste on the stove fire, take out solarization or oven dry or spray drying with gauze.Be ground into fine powder, cross 100 mesh sieves.
3, above two kinds of powder are contained in the blender, stirred 6~8 minutes, make it abundant mix homogeneously, incapsulate with 0.5 gram then.The invention has the advantages that medicine is that kinds of traditional Chinese medicines is made capsulation, so more convenient than Chinese medicine on taking.
And the present invention has heat-clearing and toxic substances removing, eliminating stasis and resolving masses, and the function that spleen invigorating is regulated the flow of vital energy, to pulmonary carcinoma, uterus carcinoma, ovarian cancer, the brain cancer, esophageal carcinoma, laryngeal carcinoma disease, bladder cancer, nasopharyngeal carcinoma, waiting all has better curative effect, and stronger analgesic activity is arranged, and is comparatively effectively medicine of anti-curing cancers.
The present invention can be achieved by the following example.
Embodiment 1: prepare by following Chinese drug-treated group part: (% is a total weight percent)
Rhizoma Arisaematis 2.4% Radix Trichosanthis 2.4%
The Rhizoma Pinelliae 2.8% Radix Salviae Miltiorrhizae 2.8%
Radix Sophorae Tonkinensis 2.8% stir-baked SQUAMA MANITIS 2.8%
Carapax Trionycis 2.8% Radix Scrophulariae 2.8%
Rhizoma Paridis 2.8% Rhizoma Dioscoreae Septemlobae 2.8%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.8% Radix Asparagi 3.2%
Radix Ophiopogonis 3.2% Radix Stemonae 3.2%
Radix Platycodonis 3.2% Herba Houttuyniae 3.2%
The Radix Astragali 3.2% Rhizoma Polygoni Cuspidati 4.8%
Herba Scutellariae Barbatae 4.8% Spica Prunellae 10%
Herba Hedyotidis Diffusae 10% Sargassum 10%
Rhizoma Smilacis Glabrae 2.4% Radix Et Rhizoma Rhei 1.1%
Semen Arecae 2% Semen Pharbitidis 1.8%
Nidus Vespae 1.8% Endothelium Corneum Gigeriae Galli 1.8%
System Semen Strychni 0.3%
Embodiment 2: prepare by following Chinese drug-treated group part: (% is a total weight percent)
Rhizoma Arisaematis 2.8% Radix Trichosanthis 2.8%
The Rhizoma Pinelliae 2.5% Radix Salviae Miltiorrhizae 2.5%
Radix Sophorae Tonkinensis 2.5% stir-baked SQUAMA MANITIS 2.5%
Carapax Trionycis 2.5% Radix Scrophulariae 2.5%
Rhizoma Paridis 2.5% Rhizoma Dioscoreae Septemlobae 2.5%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.5% Radix Asparagi 4%
Radix Ophiopogonis 4% Radix Stemonae 4%
Radix Platycodonis 4% Herba Houttuyniae 4%
The Radix Astragali 4% Rhizoma Polygoni Cuspidati 6%
Herba Scutellariae Barbatae 6% Spica Prunellae 8%
Herba Hedyotidis Diffusae 8% Sargassum 8%
Rhizoma Smilacis Glabrae 3% Radix Et Rhizoma Rhei 0.95%
Semen Arecae 1.6% Semen Pharbitidis 2%
Nidus Vespae 2% Endothelium Corneum Gigeriae Galli 2.1%
System Semen Strychni 0.25%
Semen Arecae in the above component and Semen Pharbitidis can replace with the equivalent Polyporus.
When preparation medicine of the present invention, can follow these steps to carry out:
1, with Endothelium Corneum Gigeriae Galli, stir-baked SQUAMA MANITIS, Semen Strychni (processed), Rhizoma Paridis and Rhizoma Arisaematis are ground into fine powder, 100 mesh sieve standbies.
2, all the other medicament mixed, clear water is cleaned, and washes in a pan and removes silt, contains in the stainless-steel pan, adds water three sesquialters, puts on the stove fire, and slow fire boiling one hour leaches medicine juice, adds the water half as much again again, and slow fire boiling one hour leaches medicine juice, removes slag.Mix frying in shallow oil juice for twice again, filter in the stainless-steel pan, put that slow fire boiling becomes paste on the stove fire, take out solarization or oven dry or spray drying with gauze.Be ground into fine powder, cross 100 mesh sieves.
3。Above two kinds of powder are contained in the blender, stirred 6~8 minutes, make it abundant mix homogeneously, incapsulate with 0.5 gram then.
Claims (2)
1, a kind of cancer therapy drug of being made up of Chinese medicine is that the powder that the dress kinds of traditional Chinese medicines is made in the medicinal Caplet is formed, and it is characterized in that the Chinese medicine component is: (% is a total weight percent)
Rhizoma Arisaematis 2.4%~3% Radix Trichosanthis 2.4%~3%
The Rhizoma Pinelliae 2.4%~3% Radix Salviae Miltiorrhizae 2.4%~3%
Radix Sophorae Tonkinensis 2.4%~3% stir-baked SQUAMA MANITIS 2.4%~3%
Carapax Trionycis 2.4%~3% Radix Scrophulariae 2.4%~3%
Rhizoma Paridis 2.4%~3% Rhizoma Dioscoreae Septemlobae 2.4%~3%
The Pseudobulbus Bletillae (Rhizoma Bletillae) 2.4%~3% Radix Asparagi 3.2%~4%
Radix Ophiopogonis 3.2%~4% Radix Stemonae 3.2%~4%
Radix Platycodonis 3.2%~4% Herba Houttuyniae 3.2%~4%
The Radix Astragali 3.2%~4% Rhizoma Polygoni Cuspidati 4.8%~6%
Herba Scutellariae Barbatae 4.8%~6% Spica Prunellae 8%~10%
Serpentis SHECAO 8%~10% Sargassum 8%~10%
Poria 2.4%~3% Radix Et Rhizoma Rhei 0.9%~1.1%
Semen Arecae 1.6%~2% Semen Pharbitidis 1.8%~2%
Nidus Vespae 1.8%~2% Endothelium Corneum Gigeriae Galli 1.8%~2.2%
System Semen Strychni 0.22%~0.3%
2, according to claim 1, of the present invention levying is that Semen Arecae and Semen Pharbitidis can replace with the equivalent Polyporus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93106194 CN1083714A (en) | 1993-05-18 | 1993-05-18 | A kind of cancer therapy drug of Chinese medicinal components |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93106194 CN1083714A (en) | 1993-05-18 | 1993-05-18 | A kind of cancer therapy drug of Chinese medicinal components |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1083714A true CN1083714A (en) | 1994-03-16 |
Family
ID=4986117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 93106194 Pending CN1083714A (en) | 1993-05-18 | 1993-05-18 | A kind of cancer therapy drug of Chinese medicinal components |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1083714A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1057690C (en) * | 1996-10-18 | 2000-10-25 | 宁振峰 | Chinese Patent medicine |
CN1058882C (en) * | 1996-09-24 | 2000-11-29 | 来春荣 | Oral liquor for treating tumour and disease of liver, and preparation method thereof |
CN1060659C (en) * | 1995-12-22 | 2001-01-17 | 徐瑞新 | Pill medicine for cancer and preparation method |
CN1305513C (en) * | 2005-10-27 | 2007-03-21 | 吴军杰 | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process |
CN100518789C (en) * | 2007-03-09 | 2009-07-29 | 阮玉江 | Medicine for treating cancer and preparing method therefor |
CN103417877A (en) * | 2012-05-23 | 2013-12-04 | 余长成 | Cancer treatment and prevention by utilization of herbal medicine |
US10172904B2 (en) * | 2008-09-25 | 2019-01-08 | Lifebiotic Medical Research Ltd | Herbal formulations |
-
1993
- 1993-05-18 CN CN 93106194 patent/CN1083714A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060659C (en) * | 1995-12-22 | 2001-01-17 | 徐瑞新 | Pill medicine for cancer and preparation method |
CN1058882C (en) * | 1996-09-24 | 2000-11-29 | 来春荣 | Oral liquor for treating tumour and disease of liver, and preparation method thereof |
CN1057690C (en) * | 1996-10-18 | 2000-10-25 | 宁振峰 | Chinese Patent medicine |
CN1305513C (en) * | 2005-10-27 | 2007-03-21 | 吴军杰 | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process |
CN100518789C (en) * | 2007-03-09 | 2009-07-29 | 阮玉江 | Medicine for treating cancer and preparing method therefor |
US10172904B2 (en) * | 2008-09-25 | 2019-01-08 | Lifebiotic Medical Research Ltd | Herbal formulations |
CN103417877A (en) * | 2012-05-23 | 2013-12-04 | 余长成 | Cancer treatment and prevention by utilization of herbal medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1132643A (en) | Medicine for diseases of liver and gall | |
CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
CN1083714A (en) | A kind of cancer therapy drug of Chinese medicinal components | |
CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
CN1250264C (en) | Capsule for curing hyperplasia of mammary glands and its preparation method | |
CN1294015A (en) | Medicine for treating thyroid enlargement and thyroidism | |
CN1061552C (en) | Epilepsy recovering pill and preparing process thereof | |
CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
CN1785391A (en) | Chinese medicinal composition and its preparation method | |
CN1050051C (en) | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy | |
CN1223886A (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
CN1136939A (en) | Chinese drugs for curing hepatitis B | |
CN1074292C (en) | Cancer treating medicine capsule | |
CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
CN1086129C (en) | Hepatitis restoration pill | |
CN1249191A (en) | Powdered medicine for treating vasculitis and its preparing process | |
CN1449773A (en) | Chinese patent drug for treating gastric ulcer and its preparation method | |
CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
CN1356117A (en) | Capsule 'Tangniaoshenkang' for treating diabetes | |
CN1186036C (en) | Diabetes treating medicine and its prepn | |
CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
CN1259956C (en) | Chinese medicine composition for treating heart, kidney and multiple-organ failure and its prepn | |
CN1127968C (en) | Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method | |
CN1334114A (en) | Chinese medicine for treating mastoplasia | |
CN1144123A (en) | Prescription of Xinmaitai and its production process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |